新生儿重症监护病房的药物使用情况。
Medication use in the neonatal intensive care unit.
作者信息
Hsieh Emily M, Hornik Christoph P, Clark Reese H, Laughon Matthew M, Benjamin Daniel K, Smith P Brian
机构信息
Duke-National University of Singapore Graduate Medical School, Singapore.
Duke University Medical Center, Duke Clinical Research Institute, Durham, North Carolina.
出版信息
Am J Perinatol. 2014 Oct;31(9):811-21. doi: 10.1055/s-0033-1361933. Epub 2013 Dec 17.
Abstract
OBJECTIVE
The aim of the article is to provide an update on medication use in infants admitted to the neonatal intensive care unit (NICU) in the United States and examine how use has changed over time.
STUDY DESIGN
We performed a retrospective review (2005-2010) of a large prospectively collected administrative database.
RESULT
Medications most commonly administered during the study period were ampicillin, gentamicin, caffeine citrate, vancomycin, beractant, furosemide, fentanyl, dopamine, midazolam, and calfactant (56-681 exposures per 1,000 infants). Those with the greatest relative increase in use included azithromycin, sildenafil, and milrinone. Medications with the greatest relative decrease in use included theophylline, metoclopramide, and doxapram.
CONCLUSION
Medication use in the NICU has changed substantially over time, and only 35% of the most commonly prescribed medications are Food and Drug Administration -approved in infants.
摘要
目的
本文旨在提供美国新生儿重症监护病房（NICU）收治婴儿用药情况的最新信息，并研究用药情况随时间的变化。
研究设计
我们对一个大型前瞻性收集的行政数据库进行了回顾性分析（2005 - 2010年）。
结果
研究期间最常用的药物是氨苄西林、庆大霉素、枸橼酸咖啡因、万古霉素、贝拉克坦、呋塞米、芬太尼、多巴胺、咪达唑仑和卡肺表面活性蛋白（每1000名婴儿中有56 - 681次用药）。使用量相对增加最多的药物包括阿奇霉素、西地那非和米力农。使用量相对减少最多的药物包括茶碱、甲氧氯普胺和多沙普仑。
结论
随着时间的推移，NICU的用药情况发生了很大变化，最常用的药物中只有35%是美国食品药品监督管理局批准用于婴儿的。
相似文献
1
Medication use in the neonatal intensive care unit.新生儿重症监护病房的药物使用情况。
Am J Perinatol. 2014 Oct;31(9):811-21. doi: 10.1055/s-0033-1361933. Epub 2013 Dec 17.
2
Medication Use in the Neonatal Intensive Care Unit and Changes from 2010 to 2018.新生儿重症监护病房的药物使用情况及 2010 年至 2018 年的变化。
J Pediatr. 2022 Jan;240:66-71.e4. doi: 10.1016/j.jpeds.2021.08.075. Epub 2021 Sep 2.
3
Reported medication use in the neonatal intensive care unit: data from a large national data set.新生儿重症监护病房上报的药物使用情况：来自大型全国数据集的数据
Pediatrics. 2006 Jun;117(6):1979-87. doi: 10.1542/peds.2005-1707.
4
Epidemiologic Trends in Neonatal Intensive Care, 2007-2012.2007-2012 年新生儿重症监护的流行病学趋势。
JAMA Pediatr. 2015 Sep;169(9):855-62. doi: 10.1001/jamapediatrics.2015.1305.
5
Characterization of the triage process in neonatal intensive care.新生儿重症监护中分诊过程的特征描述。
Pediatrics. 1998 Dec;102(6):1432-6. doi: 10.1542/peds.102.6.1432.
6
Postsurgery analgesic and sedative drug use in a French neonatal intensive care unit: A single-center retrospective cohort study.法国新生儿重症监护病房术后镇痛和镇静药物的使用：一项单中心回顾性队列研究。
Arch Pediatr. 2019 Apr;26(3):145-150. doi: 10.1016/j.arcped.2019.02.011. Epub 2019 Mar 15.
7
Trends in neonatal intensive care unit admissions by race/ethnicity in the United States, 2008-2018.美国种族/民族的新生儿重症监护病房入院趋势，2008-2018 年。
Sci Rep. 2021 Dec 10;11(1):23795. doi: 10.1038/s41598-021-03183-1.
8
Unlicensed and Off-Label Medication Use in Pediatric and Neonatal Intensive Care Units: No Change Over a Decade.儿科和新生儿重症监护病房未授权和标签外用药的使用：十年来没有变化。
Adv Ther. 2018 Jul;35(7):1122-1132. doi: 10.1007/s12325-018-0732-y. Epub 2018 Jun 15.
9
Safety of milrinone use in neonatal intensive care units.米力农在新生儿重症监护病房使用的安全性。
Early Hum Dev. 2015 Jan;91(1):31-5. doi: 10.1016/j.earlhumdev.2014.10.007. Epub 2014 Nov 26.
10
Off-label and unlicensed drug use in a Spanish Neonatal Intensive Care Unit.西班牙新生儿重症监护病房中的药品未按说明书使用及未获许可使用情况。
Farm Hosp. 2017 May 1;41(3):371-381. doi: 10.7399/fh.2017.41.3.10691.
引用本文的文献
1
Cataloging Actionable Pharmacogenomic Variants for Indian Clinical Practice: A Scoping Review.为印度临床实践编目可操作的药物基因组变异：一项范围综述
J Xenobiot. 2025 Jul 1;15(4):101. doi: 10.3390/jox15040101.
2
Medication use in the neonatal intensive care unit in a tertiary hospital in China from 2020 to 2023.2020年至2023年中国一家三级医院新生儿重症监护病房的用药情况
Ital J Pediatr. 2025 May 19;51(1):142. doi: 10.1186/s13052-025-02003-w.
3
Current and Emerging Therapies for Prevention and Treatment of Bronchopulmonary Dysplasia in Preterm Infants.预防和治疗早产儿支气管肺发育不良的现有及新出现的疗法
Paediatr Drugs. 2025 May 15. doi: 10.1007/s40272-025-00697-3.
4
Absence of association between early antibiotic exposure and short-term adverse outcomes in very preterm infants: a single-center retrospective study.极早产儿早期抗生素暴露与短期不良结局之间无关联：一项单中心回顾性研究。
Front Pediatr. 2025 Mar 17;13:1563979. doi: 10.3389/fped.2025.1563979. eCollection 2025.
5
A Pediatric Research Imperative: Addressing Neonates in Drug Development Through Understanding Neonatal Clinical Pharmacology.儿科研究的当务之急：通过理解新生儿临床药理学在药物研发中关注新生儿
J Pediatr Pharmacol Ther. 2025 Feb;30(1):8-16. doi: 10.5863/1551-6776-30.1.8. Epub 2025 Feb 10.
6
Theoretical impact of a bedside decision-making tool on antibiotic use for suspected neonatal healthcare-associated infection: an observational study.床边决策工具对疑似新生儿医疗保健相关感染抗生素使用的理论影响：一项观察性研究。
BMC Pediatr. 2025 Jan 21;25(1):52. doi: 10.1186/s12887-024-05323-8.
7
Profile of antimicrobial use and potential use of the defined daily dose in neonatology.新生儿科抗菌药物使用情况及限定日剂量的潜在应用分析。
Sci Rep. 2024 Oct 3;14(1):22979. doi: 10.1038/s41598-024-74559-2.
8
Clinical sequelae of gut microbiome development and disruption in hospitalized preterm infants.住院早产儿肠道微生物组发育和失调的临床后果。
Cell Host Microbe. 2024 Oct 9;32(10):1822-1837.e5. doi: 10.1016/j.chom.2024.07.027. Epub 2024 Aug 27.
9
Antibiotics, Analgesic Sedatives, and Antiseizure Medications Frequently Used in Critically Ill Neonates: A Narrative Review.危重新生儿常用抗生素、镇痛镇静药及抗惊厥药：一项叙述性综述
Children (Basel). 2024 Jul 18;11(7):871. doi: 10.3390/children11070871.
10
Early Antibiotic Exposure and Bronchopulmonary Dysplasia in Very Preterm Infants at Low Risk of Early-Onset Sepsis.早期抗生素暴露与低早发性败血症风险的极早产儿支气管肺发育不良。
JAMA Netw Open. 2024 Jun 3;7(6):e2418831. doi: 10.1001/jamanetworkopen.2024.18831.
本文引用的文献
1
Long term respiratory outcomes of very premature birth (<32 weeks).极早产儿（<32 周）的长期呼吸系统结局。
Semin Fetal Neonatal Med. 2012 Apr;17(2):73-6. doi: 10.1016/j.siny.2012.01.009. Epub 2012 Feb 1.
2
A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension.一项随机、双盲、安慰剂对照、剂量范围研究，评估口服西地那非治疗肺动脉高压未治疗的儿童。
Circulation. 2012 Jan 17;125(2):324-34. doi: 10.1161/CIRCULATIONAHA.110.016667. Epub 2011 Nov 29.
3
Strategies to prevent invasive candidal infection in extremely preterm infants.预防极早产儿侵袭性念珠菌感染的策略。
Clin Perinatol. 2010 Sep;37(3):611-28. doi: 10.1016/j.clp.2010.06.003.
4
The Pediatrix BabySteps Data Warehouse and the Pediatrix QualitySteps improvement project system--tools for "meaningful use" in continuous quality improvement.Pediatrix BabySteps 数据仓库和 Pediatrix QualitySteps 改善项目系统——持续质量改进中“有意义使用”的工具。
Clin Perinatol. 2010 Mar;37(1):49-70. doi: 10.1016/j.clp.2010.01.016.
5
Patience is a virtue in the management of gastroesophageal reflux.耐心是胃食管反流管理中的一项美德。
J Pediatr. 2009 Oct;155(4):464-5. doi: 10.1016/j.jpeds.2009.05.014.
6
Population pharmacokinetics of fluconazole in young infants.氟康唑在婴幼儿中的群体药代动力学
Antimicrob Agents Chemother. 2008 Nov;52(11):4043-9. doi: 10.1128/AAC.00569-08. Epub 2008 Sep 22.
7
A multicenter, randomized trial of prophylactic fluconazole in preterm neonates.一项针对早产儿预防性使用氟康唑的多中心随机试验。
N Engl J Med. 2007 Jun 14;356(24):2483-95. doi: 10.1056/NEJMoa065733.
8
Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety.不同环境下新生儿及儿童的超说明书用药与未获许可用药：文献综述及药物安全性考量
Expert Opin Drug Saf. 2006 Sep;5(5):703-18. doi: 10.1517/14740338.5.5.703.
9
Metoclopramide for the treatment of gastroesophageal reflux disease in infants: a systematic review.甲氧氯普胺治疗婴儿胃食管反流病：一项系统评价。
Pediatrics. 2006 Aug;118(2):746-52. doi: 10.1542/peds.2005-2664.
10
Reported medication use in the neonatal intensive care unit: data from a large national data set.新生儿重症监护病房上报的药物使用情况：来自大型全国数据集的数据
Pediatrics. 2006 Jun;117(6):1979-87. doi: 10.1542/peds.2005-1707.
Zotero 插件